SCHEMBL17404757

SCHEMBL17404757

CN1Cc2cnc(N)cc2C1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOS3 P29474 3/20 0.50
NOS1 P29475 3/20 0.50
NOS2 P35228 3/20 0.50
PIK3CB P42338 1/20 0.39
CHRNB2 P17787 1/20 0.37
CHRNA4 P43681 1/20 0.37
NAMPT P43490 2/20 0.36
HRH4 Q9H3N8 2/20 0.34
HRH3 Q9Y5N1 1/20 0.34
ROCK2 O75116 1/20 0.34
ROCK1 Q13464 1/20 0.34
MEN1 O00255 1/20 0.33
GLA P06280 1/20 0.33
GAA P10253 1/20 0.33
KMT2A Q03164 1/20 0.33
RPS6KA3 P51812 1/20 0.33
PDPK1 O15530 1/20 0.33
MAOA P21397 1/20 0.32
MAOB P27338 1/20 0.32
SLC6A4 P31645 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28935704 0.78 NOS1 (0.64) NOS3NOS1NOS2PIK3CBHRH4
SCHEMBL16181319 0.77 UHRF1 (0.35) MAOAMAOBSLC6A4
SCHEMBL21936088 0.75 CHRNB2 (0.38) CHRNB2CHRNA4HRH4MAOAMAOB
SCHEMBL18616050 0.75 MAOA (0.32) MAOAMAOBSLC6A4
SCHEMBL17624453 0.72 HDAC1 (0.37) HRH4HRH3MAOAMAOBSLC6A4
SCHEMBL17624454 0.72 SLC6A4 (0.42) CHRNB2CHRNA4HRH3MAOAMAOB
SCHEMBL17624455 0.72 EED (0.36) MAOAMAOBSLC6A4
SCHEMBL21267647 0.72 USP9X (0.31) MAOAMAOBSLC6A4
SCHEMBL12706078 0.71 MAOA (0.44) MAOAMAOBSLC6A4
SCHEMBL17624451 0.71 PDE10A (0.35) HRH4MAOAMAOBSLC6A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9822129-B2 Amido spirocyclic amide and sulfonamide derivatives GENENTECH, INC. (US) 2017-11-21 US disclosed
US-20170216262-A1 AMIDO SPIROCYCLIC AMIDE AND SULFONAMIDE DERIVATIVES VALO EARLY DISCOVERY, INC. 2017-08-03 US disclosed
US-20160002266-A1 AMIDO SPIROCYCLIC AMIDE AND SULFONAMIDE DERIVATIVES GENENTECH, INC. (US) 2016-01-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160002266-A1 AMIDO SPIROCYCLIC AMIDE AND SULFONAMIDE DERIVATIVES STS, AADAC, SULT2A1 NOS3 3300/4885NOS1 3523/4885NOS2 2486/4885
US-20170216262-A1 AMIDO SPIROCYCLIC AMIDE AND SULFONAMIDE DERIVATIVES STS, AADAC, SULT2A1 NOS3 3300/4885NOS1 3523/4885NOS2 2486/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.